Skip to main content
. Author manuscript; available in PMC: 2009 Nov 19.
Published in final edited form as: Bioconjug Chem. 2008 Nov 19;19(11):2120–2128. doi: 10.1021/bc8002138

Figure 3.

Figure 3

Representative fluorescence micrographs (10X) of EGFP Expression in COS-7 cells treated with lipoplexes formed from A) pEGFP-N1 and 10 μM reduced BFDMA, B) pEGFP-N1 and oxidized BFDMA, and C) pEGFP-N1 and oxidized BFDMA and treated with a 20-fold excess of GSH following lipoplex formation. Images were acquired at 48 h after exposure of cells to lipoplexes in serum-free medium (see text).